v3.25.3
Condensed Consolidated Statements of Operations, Unaudited - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Revenues $ 0 $ 0 $ 0 $ 0
Costs and Expenses        
Operating expenses 646,000 231,000 12,050,000 758,000
Research and development expenses 1,244,000 48,000 1,395,000 143,000
Loss from operations (1,890,000) (279,000) (13,445,000) (901,000)
Other income (expense)        
Interest expense (74,000) (86,000) (332,000) (246,000)
Net Loss $ (1,964,000) $ (365,000) $ (13,777,000) $ (1,147,000)
Net loss per common share, basic $ (0.00) $ (0.00) $ (0.03) $ (0.00)
Net loss per common share, diluted $ (0.00) $ (0.00) $ (0.03) $ (0.00)
Weighted average common shares outstanding, basic 525,140,131 406,763,985 486,610,294 399,574,212
Weighted average common shares outstanding, diluted 525,140,131 406,763,985 486,610,294 399,574,212

Source